Success Metrics

Clinical Success Rate
80.0%

Based on 12 completed trials

Completion Rate
80%(12/15)
Active Trials
8(30%)
Results Posted
17%(2 trials)
Terminated
3(11%)

Phase Distribution

Ph phase_1
3
11%
Ph phase_3
3
11%
Ph not_applicable
12
44%
Ph phase_4
1
4%
Ph early_phase_1
3
11%

Phase Distribution

6

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution22 total trials
Early Phase 1First-in-human
3(13.6%)
Phase 1Safety & dosage
3(13.6%)
Phase 3Large-scale testing
3(13.6%)
Phase 4Post-market surveillance
1(4.5%)
N/ANon-phased studies
12(54.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.6%

12 of 17 finished

Non-Completion Rate

29.4%

5 ended early

Currently Active

8

trials recruiting

Total Trials

27

all time

Status Distribution
Active(8)
Completed(12)
Terminated(5)
Other(2)

Detailed Status

Completed12
Recruiting4
Active, not recruiting4
Terminated3
Withdrawn2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
27
Active
8
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (13.6%)
Phase 13 (13.6%)
Phase 33 (13.6%)
Phase 41 (4.5%)
N/A12 (54.5%)

Trials by Status

withdrawn27%
recruiting415%
unknown27%
terminated311%
active_not_recruiting415%
completed1244%

Recent Activity

Clinical Trials (27)

Showing 20 of 27 trialsScroll for more
NCT04754581Not Applicable

Dynamic in Vivo PET Imaging and ex Vivo Biopsies From Skeletal Muscle and Adipose Tissue to Investigate the Effects of Exercise on Insulin Resistance and Mitochondrial Energetics in Type 2 Diabetes

Active Not Recruiting
NCT06586047Early Phase 1

Breast Cancer PSMA PET

Recruiting
NCT03535545Phase 1

Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients

Recruiting
NCT03196518Not Applicable

Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer

Active Not Recruiting
NCT05634031Not Applicable

Imaging Coronary Microvascular Dysfunction (CMD) Study

Recruiting
NCT05753995Not Applicable

Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study

Active Not Recruiting
NCT03434548

IMarkHD: in Vivo Longitudinal Imaging of HD Pathology

Recruiting
NCT00708448Phase 1

Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients

Completed
NCT03298009Not Applicable

Impact of a Short-term Treatment With Canagliflozin (Canacardia-HF)

Withdrawn
NCT02023996Not Applicable

PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer

Completed
NCT04073810

Residual Inflammation and Plaque Progression Long-term Evaluation

Active Not Recruiting
NCT00633958Phase 1

A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) Tumors

Terminated
NCT04600115Early Phase 1

New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF)

Unknown
NCT02608944Not Applicable

Comparison of Quantitative MRI Perfusion Methods With Quantitative PET Perfusion Imaging

Withdrawn
NCT02038595Early Phase 1

The Norepinephrine Transporter: A Novel Target for Imaging Brown Adipose Tissue

Completed
NCT00585117Not Applicable

Pilot Study of (61)CuATSM-PET Imaging in Cancer Patients

Terminated
NCT00385242Phase 3

PET and Recovery Following Revascularization (PARR 2)

Completed
NCT04088344Not Applicable

Effect of a Carbohydrate-rich Diet in Healthy Subjects

Completed
NCT03815838Not Applicable

Molecular Imaging of Pituitary Adenomas

Unknown
NCT02895932Not Applicable

Serotonin and Amyloidopathy

Completed

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
27